The DOI matches its Crossref record; 355 of the 355 references it cites were found in a registry or an index.
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Open accessAbstract
The search for treatments for neurodegenerative diseases is a major concern in light of today’s aging population and an increasing burden on individuals, families and society. Although great advances have been made in the last decades to understand the underlying genetic and biological cause of these diseases, only some symptomatic treatments are available. Metformin has long since been used to treat Type 2 Diabetes and has been shown to be beneficial in several other conditions. Metformin is well-tested in vitro and an approved compound that targets diverse pathways including mitochondrial energy production and insulin signaling. There is growing evidence for the benefits of metformin to counteract age-related diseases such as cancer, cardiovascular disease and neurodegenerative diseases. We will discuss evidence showing that certain neurodegenerative diseases and diabetes are explicitly linked and that metformin along with other diabetes drugs can reduce neurological symptoms in some patients and reduce disease phenotypes in animal and cell models. An interesting therapeutic factor might be how metformin is able to balance survival and death signaling in cells through pathways that are commonly associated with neurodegenerative diseases. In healthy neurons, these overarching signals keep energy metabolism, oxidative stress and proteostasis in check, avoiding the dysfunction and neuronal death that defines neurodegenerative disease. We will discuss the biological mechanisms involved and the relevance of neuronal vulnerability and potential difficulties for future trials and development of therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–355 of 355
Malagelada, C., Jin, Z. H., & Greene, L. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3928-08.2008 · Cited by 228
Metformin therapy in a transgenic mouse model of Huntington's disease
Ma, T. C., Buescher, J. L., Oatis, B., Funk, J. A., Nash, A. J., Carrier, R. L., & Hoyt, K. R. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.039 · Cited by 222
Wisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221
van der Brug, M. P., Blackinton, J., Chandran, J., Hao, L.-Y., Lal, A., Mazan-Mamczarz, K., Martindale, J., Xie, C., Ahmad, R., Thomas, K. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708518105 · Cited by 219
Zakikhani, M., Blouin, M.-J., Piura, E., & Pollak, M. N. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0763-9 · Cited by 213
Diabetes Mellitus and Dementia
Ninomiya, T. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0487-z · Cited by 212
Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study.
Brion, J., Couck, A. M., Passareiro, E., & Flament-Durand, J. (1985) · PubMed · Cited by 209
Diabetes and the Risk of Developing Parkinson’s Disease in Denmark
Schernhammer, E., Hansen, J., Rugbjerg, K., Wermuth, L., & Ritz, B. (2011) · Diabetes Care · doi:10.2337/dc10-1333 · Cited by 198
Woo, S.-L., Xu, H., Li, H., Zhao, Y., Hu, X., Zhao, J., Guo, X., Guo, T., Botchlett, R., Qi, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091111 · Cited by 194
Akt signal transduction dysfunction in Parkinson's disease
Timmons, S., Coakley, M. F., Moloney, A. M., & O’ Neill, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.055 · Cited by 192
Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells
Greco, S. J., Sarkar, S., Johnston, J. M., & Tezapsidis, N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.041 · Cited by 191
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer
Matassa, D. S., Amoroso, M. R., Lu, H., Avolio, R., Arzeni, D., Procaccini, C., Faicchia, D., Maddalena, F., Simeon, V, Agliarulo, I., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.39 · Cited by 191
Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology
Beeri, M. S., Silverman, J. M., Davis, K. L., Marin, D., Grossman, H. Z., Schmeidler, J., Purohit, D. P., Perl, D. P., Davidson, M., Mohs, R. C., et al. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.4.471 · Cited by 188
Yue, X., Li, H., Yan, H., Zhang, P., Chang, L., & Li, T. (2016) · Medicine · doi:10.1097/md.0000000000003549 · Cited by 187
Effect of pioglitazone medication on the incidence of dementia
Heneka, M. T., Fink, A., & Doblhammer, G. (2015) · Annals of Neurology · doi:10.1002/ana.24439 · Cited by 185
Thornton, C., Bright, N. J., Sastre, M., Muckett, P. J., & Carling, D. (2011) · Biochemical Journal · doi:10.1042/bj20101485 · Cited by 184
Wu, W., Xu, H., Wang, Z., Mao, Y., Yuan, L., Luo, W., Cui, Z., Cui, T., Wang, X. L., & Shen, Y. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132499 · Cited by 182
Caccamo, A., De Pinto, V., Messina, A., Branca, C., & Oddo, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0777-14.2014 · Cited by 182
Ng, C.-H., Guan, M. S. H., Koh, C., Ouyang, X., Yu, F., Tan, E.-K., O'Neill, S. P., Zhang, X., Chung, J., & Lim, K.-L. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0499-12.2012 · Cited by 176
Pathways to Alzheimer's disease
Hardy, J., Bogdanovic, N., Winblad, B., Portelius, E., Andreasen, N., Cedazo‐Minguez, A., & Zetterberg, H. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12192 · Cited by 176
Katila, N., Bhurtel, S., Shadfar, S., Srivastav, S., Neupane, S., Ojha, U., Jeong, G.-S., & Choi, D.-Y. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.015 · Cited by 169
Kuan, Y.-C., Huang, K.-W., Lin, C.-L., Hu, C.-J., & Kao, C.-H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.002 · Cited by 168
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Driver, J. A., Smith, A., Buring, J. E., Gaziano, J. M., Kurth, T., & Logroscino, G. (2008) · Diabetes Care · doi:10.2337/dc08-0688 · Cited by 168
Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis
Cheng, C., Lin, C.-H., Tsai, Y.-W., Tsai, C.-J., Chou, P.-H., & Lan, T.-H. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu073 · Cited by 167
Dupuis, L., Dengler, R., Heneka, M. T., Meyer, T., Zierz, S., Kassubek, J., Fischer, W., Steiner, F., Lindauer, E., Otto, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037885 · Cited by 167
Insulin resistance impairs nigrostriatal dopamine function
Morris, J. K., Bomhoff, G. L., Gorres, B. K., Davis, V. A., Kim, J., Lee, P., Brooks, W. M., Gerhardt, G. A., Geiger, P. C., & Stanford, J. A. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.005 · Cited by 167
Sugama, S., Yang, L., Cho, B. P., DeGiorgio, L. A., Lorenzl, S., Albers, D. S., Beal, M. F., Volpe, B. T., & Joh, T. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04085-4 · Cited by 164
PTEN inhibits IL-2 receptor-mediated expansion of CD4+CD25+ Tregs
Walsh, P. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28057 · Cited by 164
Neurodegeneration in an animal model of Parkinson’s disease is exacerbated by a high-fat diet
Morris, J. K., Bomhoff, G. L., Stanford, J. A., & Geiger, P. C. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00449.2010 · Cited by 163
Akt is altered in an animal model of Huntington's disease and in patients
Colin, E., Régulier, E., Perrin, V., Dürr, A., Brice, A., Aebischer, P., Déglon, N., Humbert, S., & Saudou, F. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03985.x · Cited by 163
Goodarzi, M. O., & Bryer‐Ash, M. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00448.x · Cited by 162
Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes
Moulton, C. D., Costafreda, S. G., Horton, P., Ismail, K., & Fu, C. H. Y. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-014-9348-2 · Cited by 161
Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
Bosco, D., Plastino, M., Cristiano, D., Colica, C., Ermio, C., De Bartolo, M., Mungari, P., Fonte, G., Consoli, D., Consoli, A., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.12.008 · Cited by 161
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes
Orkaby, A. R., Cho, K., Cormack, J., Gagnon, D. R., & Driver, J. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004586 · Cited by 161
A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease
FRÖLICH, L., BLUM‐DEGEN, D., RIEDERER, P., & HOYER, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07839.x · Cited by 160
Diabetes drugs and neurological disorders: new views and therapeutic possibilities
Patrone, C., Eriksson, O., & Lindholm, D. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70125-6 · Cited by 160
Malek, N., Lawton, M. A., Swallow, D. M. A., Grosset, K. A., Marrinan, S. L., Bajaj, N., Barker, R. A., Burn, D. J., Hardy, J., Morris, H. R., et al. (2016) · Movement Disorders · doi:10.1002/mds.26698 · Cited by 158
Lalic, N. M., Marić, J., Svetel, M. V., Jotić, A., Stefanova, E. D., Lalic, K. S., Dragašević, N., Milicic, T. J., Lukić, L., & Kostić, V. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.476 · Cited by 154
Miyake, Y., Tanaka, K., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.002 · Cited by 154
The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity
Butler, E. K., Voigt, A., Lutz, A. K., Toegel, J. P., Gerhardt, E., Karsten, P., Falkenburger, B. H., Reinartz, A., Winklhofer, K. F., & Schulz, J. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002488 · Cited by 152
Sarfstein, R., Friedman, Y., Attias-Geva, Z., Fishman, A., Bruchim, I., & Werner, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061537 · Cited by 150
Chen, F., Dong, R. R., Zhong, K. L., Ghosh, A., Tang, S. S., Long, Y., Hu, M. Y., Miao, M. X., Liao, J. M., Sun, H. B., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.023 · Cited by 148
Heneka, M. T., Wiesinger, H., Dumitrescu‐Ozimek, L., Riederer, P. F., Feinstein, D. L., & Klockgether, T. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.906 · Cited by 148
Clinical and Pathological Features of Parkinson’s Disease
Schneider, S. A., & Obeso, J. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_317 · Cited by 147
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study
Kioumourtzoglou, M.-A., Rotem, R. S., Seals, R. M., Gredal, O., Hansen, J., & Weisskopf, M. G. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0910 · Cited by 145
Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy
Wang, C., Yu, J., Miao, D., Wu, Z., Tan, M., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8505-8 · Cited by 142
Pérez-Revuelta, B. I., Hettich, M. M., Ciociaro, A., Rotermund, C., Kahle, P. J., Krauss, S., & Di Monte, D. A. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.175 · Cited by 140
Self-citationSiddiqui, A., Bhaumik, D., Chinta, S. J., Rane, A., Rajagopalan, S., Lieu, C. A., Lithgow, G. J., & Andersen, J. K. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0109-15.2015 · Cited by 137
Mullard, A. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.4 · Cited by 137
Differential effects of metformin on age related comorbidities in older men with type 2 diabetes
Wang, C.-P., Lorenzo, C., Habib, S. L., Jo, B., & Espinoza, S. E. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.013 · Cited by 134 · cited 2×
“They concluded that the effect of metformin may in fact differ depending on the risk-profile of patient receiving the drug (100).”
BackgroundSimón‐Sánchez, J., & Singleton, A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn096 · Cited by 131
Chiang, M., Cheng, Y., Chen, S., Yen, C., & Huang, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.08.013 · Cited by 131
Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
Rasola, A., Neckers, L., & Picard, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.005 · Cited by 129
Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies
Lü, L., Fu, D.-L., Li, H., Liu, A., Li, J.-H., & Zheng, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085781 · Cited by 128
Mannucci, E., Tesi, F., Bardini, G., Ognibene, A., Mg, P., Ciani, S., Pezzatini, A., Brogi, M., Dicembrini, I., Cremasco, F., et al. (2004) · PubMed · Cited by 128
A Meta-Analysis of Cognitive Functioning in Nondemented Adults with Type 2 Diabetes Mellitus
Monette, M., Baird, A. D., & Jackson, D. L. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.014 · Cited by 126
The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
Dulović, M., Jovanović, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L. M., Kravic‐Stevovic, T., Paunović, V., Ardah, M. T., El‐Agnaf, O. M. A., Kostić, V., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.002 · Cited by 126
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., & Gasparini, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0082-7 · Cited by 126
MIRSKY, I. A., & Broh-Kahn, R. H. (1949) · PubMed · Cited by 126
Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease
Mortiboys, H., Aasly, J. O., & Bandmann, O. (2013) · Brain · doi:10.1093/brain/awt224 · Cited by 125
Wang, X., Zhai, Y., Xu, L., Qiao, C., Sun, X., Ding, J., Lu, M., & Hu, G. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.001 · Cited by 121
Association between diabetes and amyotrophic lateral sclerosis in Sweden
Mariosa, D., Kamel, F., Bellocco, R., Ye, W., & Fang, F. (2015) · European Journal of Neurology · doi:10.1111/ene.12632 · Cited by 120
Picone, P., Nuzzo, D., Caruana, L., Messina, E., Barera, A., Vasto, S., & Carlo, M. D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.017 · Cited by 118
Ruiz, H. H., Chi, T., Shin, A. C., Lindtner, C., Hsieh, W., Ehrlich, M. E., Gandy, S., & Buettner, C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.008 · Cited by 118
Kim, Y., Zheng, X., Ansari, Z., Bunnell, M. C., Herdy, J. R., Traxler, L., Lee, H., Paquola, A. C. M., Blithikioti, C., Ku, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.04.105 · Cited by 117
Mitochondrial regulation of β-cell function: Maintaining the momentum for insulin release
Kaufman, B. A., Li, C., & Soleimanpour, S. A. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.01.004 · Cited by 117
Dopamine Receptor Binding Is Increased in Diabetic Rats
Lozovsky, D. B., Saller, C. F., & Kopin, I. J. (1981) · Science · doi:10.1126/science.6458088 · Cited by 117
5′-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells
Garcia‐Gil, M., Pesi, R., Perna, S., Allegrini, S., Giannecchini, M., Camici, M., & Tozzi, M. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00836-9 · Cited by 112
Choi, J., Jang, E.-H., Park, C., & Kang, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.008 · Cited by 112
Metformin Treatment Alters Memory Function in a Mouse Model of Alzheimer's Disease
DiTacchio, K. A., Heinemann, S. F., & Dziewczapolski, G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141332 · Cited by 111
Glitazone use associated with reduced risk of Parkinson's disease
Brakedal, B., Flønes, I. H., Reiter, S. F., Torkildsen, Ø., Dölle, C., Aßmus, J., Haugarvoll, K., & Tzoulis, C. (2017) · Movement Disorders · doi:10.1002/mds.27128 · Cited by 111
Executive Function in Adults With Type 2 Diabetes: A Meta-Analytic Review
Vincent, C. M., & Hall, P. A. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000103 · Cited by 107
Ertekin‐Taner, N., Allen, M., Fadale, D. J., Scanlin, L., Younkin, L. H., Petersen, R. C., Graff‐Radford, N. R., & Younkin, S. G. (2004) · Human Mutation · doi:10.1002/humu.20016 · Cited by 106
Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease
Sun, X., Bromley‐Brits, K., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07515.x · Cited by 105
Nair, V., Pathi, S. S., Jutooru, I., Sreevalsan, S., Basha, R. M., Abdelrahim, M., Samudio, I. J., & Safe, S. H. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt231 · Cited by 104
Glenner, G. G. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.020 · Cited by 104
Choi, J., Park, C., & Jeong, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.022 · Cited by 103
Fitzgerald, J. C., Zimprich, A. A., Berrio, D. A. C., Schindler, K. M., Maurer, B., Schulte, C., Bus, C., Hauser, A., Kübler, M., Lewin, R., et al. (2017) · Brain · doi:10.1093/brain/awx202 · Cited by 102
Self-citationJiang, P., Gan, M., Ebrahim, A. S., Castanedes‐Casey, M., Dickson, D. W., & Yen, S.-H. C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.001 · Cited by 101
IGF-I and the aging mammalian brain
Piriz, J., Muller, A. P., Trejo, J. L., & Torres‐Alemán, I. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.022 · Cited by 100
Karnevi, E., Said, K., Andersson, R., & Rosendahl, A. H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-235 · Cited by 99
Parkinson Disease Protein DJ-1 Binds Metals and Protects against Metal-induced Cytotoxicity
Björkblom, B., Adilbayeva, A., Maple‐Grødem, J., Piston, D., Ökvist, M., Xu, X. M., Brede, C., Larsen, J. P., & Møller, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482091 · Cited by 99
ALS disease onset may occur later in patients with pre‐morbid diabetes mellitus
Jawaid, A., Salamone, A. R., Strutt, A. M., Murthy, S. B., Wheaton, M. W., McDowell, E. J., Simpson, E. P., Appel, S. H., York, M. K., & Schulz, P. E. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02923.x · Cited by 98
Increased Aβ production prompts the onset of glucose intolerance and insulin resistance
Jiménez-Palomares, M., Ramos‐Rodríguez, J. J., López-Acosta, J. F., Pacheco‐Herrero, M., Lechuga-Sancho, A. M., Perdomo, G., García-Alloza, M., & Cózar‐Castellano, I. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2011 · Cited by 95
AMP-Activated Protein Kinase Restricts IFN-γ Signaling
Meares, G. P., Qin, H., Liu, Y., Holdbrooks, A. T., & Benveniste, E. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202390 · Cited by 91
Metformin intake associates with better cognitive function in patients with Huntington's disease
Hervás, D., Fornés, V., Gómez-Escribano, A. P., Sequedo, M. D., Peiró, C., Millán, J. M., & Vázquez‐Manrique, R. P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179283 · Cited by 91
Adak, T., Samadi, A., Ünal, A. Z., & Sabuncuoğlu, S. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.12.023 · Cited by 91
McNeilly, A. D., Williamson, R., Balfour, D. J. K., Stewart, C. A., & Sutherland, C. D. (2012) · Diabetologia · doi:10.1007/s00125-012-2686-y · Cited by 90
Mody, N., Agouni, A., Mcilroy, G. D., Platt, B., & Delibegović, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2160-2 · Cited by 90
Glucose Metabolism: A Sweet Relief of Alzheimer’s Disease
Duran-Aniotz, C. A., & Hetz, C. A. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.060 · Cited by 90
Kaneb, H., Sharp, P. S., Kondori, N. R., & Wells, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024189 · Cited by 89
Allard, J. S., Perez, E. J., Fukui, K., Carpenter, P., Ingram, D. K., & Cabo, R. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.012 · Cited by 88
Statins in neurological disorders: An overview and update
Malfitano, A. M., Marasco, G., Proto, M., Laezza, C., Gazzerro, P., & Bifulco, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.007 · Cited by 86
Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2
Zhang, Y., Zhou, B. Z., Deng, B., Zhang, F., Wu, J., Wang, Y., Le, Y., & Zhai, Q. (2012) · Diabetes · doi:10.2337/db12-0670 · Cited by 86
Torres-Odio, S., Key, J., Hoepken, H.-H., Canet-Pons, J., Valek, L., Roller, B., Walter, M. J., Morales-Gordo, B., Meierhofer, D., Harter, P. N., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0928-0 · Cited by 86
Ismaiel, A. A., Espinosa‐Oliva, A. M., Santiago, M., García-Quintanilla, A., Oliva-Martín, M. J., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.03.004 · Cited by 85
Diabetes is Not Associated with Alzheimer’s Disease Neuropathology
Matioli, M. N. P. D. S., Suemoto, C. K., Rodriguez, R. D., Farias, D. S., da Silva, M. M., Leite, R. E. P., Ferretti‐Rebustini, R. E. D. L., Farfel, J. M., Pasqualucci, C. A., Filho, W. J., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170179 · Cited by 85
Bayliss, J. A., Lemus, M. B., dos Santos, V. V., Deo, M., Davies, J. S., Kemp, B. E., Elsworth, J. D., & Andrews, Z. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159381 · Cited by 83
Lennox, R., Porter, D. W., Flatt, P. R., Hölscher, C., Irwin, N., & Gault, V. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.026 · Cited by 82
Choi, J., Ravipati, A., Nimmagadda, V. K. C., Schubert, M., Castellani, R. J., & Russell, J. W. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.09.005 · Cited by 78
The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
Hettich, M. M., Matthes, F., Ryan, D. P., Griesche, N., Schröder, S., Dorn, S., Krauß, S., & Ehninger, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102420 · Cited by 78
Meta-analysis of risk factors for Parkinson’s disease dementia
Xu, Y., Yang, J., & Shang, H. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0058-0 · Cited by 78
Traumatic brain injury and age at onset of cognitive impairment in older adults
Li, W., Risacher, S. L., McAllister, T. W., & Saykin, A. J. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8093-4 · Cited by 77
Toxic effect of a β-amyloid peptide (β22–35) on the hippocampal neuron and its prevention
Takadera, T., Sakura, N., Mohri, T., & Hashimoto, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90135-8 · Cited by 77
Diabetes preceding Parkinson's disease onset. A case–control study
D’Amelio, M., Ragonese, P., Callari, G., Benedetto, N. D., Palmeri, B., Terruso, V., Salemi, G., Famoso, G., Aridon, P., & Savettieri, G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.013 · Cited by 76
Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection
Kang, H., Khang, R., Ham, S., Jeong, G. R., Kim, H., Jo, M., Lee, B. D., Lee, Y. I., Jo, A., Park, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18122 · Cited by 76
Diet‐induced obesity accelerates the onset of terminal phenotypes in α‐synuclein transgenic mice
Rotermund, C., Truckenmüller, F. M., Schell, H., & Kahle, P. J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12813 · Cited by 72
Self-citationPark, Y., Park, J., Kim, Y., Baek, H., & Kim, S. H. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.025 · Cited by 72
Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice
Thangthaeng, N., Rutledge, M. A., Wong, J. M., Vann, P. H., Forster, M. J., & Sumien, N. (2017) · Aging and Disease · doi:10.14336/ad.2016.1010 · Cited by 71
Insulin inhibits amyloid β-induced cell death in cultured human brain pericytes
Rensink, A. A. M., Otte-Höller, I., de Boer, R., Bosch, R. R., ten Donkelaar, H. J., de Waal, R. M. W., Verbeek, M. M., & Kremer, B. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00039-3 · Cited by 69
Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology
Pruzin, J. J., Schneider, J. A., Capuano, A. W., Leurgans, S. E., Barnes, L. L., Ahima, R. S., Arnold, S. E., Bennett, D. A., & Arvanitakis, Z. (2016) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000172 · Cited by 69
Zhang, Y., He, X., Wu, X., Lei, M., Wei, Z., Zhang, X., Wen, L., Xu, P., Li, S., & Qu, S. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.491 · Cited by 66
Levy, G., Tang, M., COTE, L. J., Louis, E. D., Alfaro, B., Mejia‐Santana, H., Stern, Y., & Marder, K. S. (2002) · Movement Disorders · doi:10.1002/mds.10086 · Cited by 62
Vascular Risk Factors and Cognition in Parkinson’s Disease
Pilotto, A., Turrone, R., Liepelt‐Scarfone, I., Bianchi, M., Poli, L., Borroni, B., Alberici, A., Premi, E., Formenti, A., Bigni, B., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150610 · Cited by 62
Sun, Y., Lu, C.-J., Chen, R.-C., Hou, W., & Li, C. (2015) · Journal of Epidemiology · doi:10.2188/jea.je20140176 · Cited by 60
Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?
Hollinger, S. K., Okosun, I. S., & Mitchell, C. S. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00047 · Cited by 60
Power, sex, suicide Mitochondria and the meaning of life
Schon, E. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29253 · Cited by 59
The role of pre‐morbid diabetes on developing amyotrophic lateral sclerosis
D'Ovidio, F., d'Errico, A., Carnà, P., Calvo, A., Costa, G., & Chiò, A. (2018) · European Journal of Neurology · doi:10.1111/ene.13465 · Cited by 59
Huntington’s Disease Does Not Appear to Increase the Risk of Diabetes Mellitus
Boesgaard, T. W., Nielsen, T. T., Josefsen, K. E., Hansen, T. F., Jørgensen, T., Pedersen, O. B., Nørremølle, A., Nielsen, J., & Hasholt, L. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01898.x · Cited by 55
Huntington’s Disease and Diabetes: Chronological Sequence of its Association
Montojo, M. T., Aganzo, M., & González, N. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-170253 · Cited by 55
Defects in mitophagy promote redox‐driven metabolic syndrome in the absence of TP53INP1
Seillier, M., Pouyet, L., N’guessan, P., Nollet, M., Capo, F., Guillaumond, F., Peyta, L., Dumas, J., Varrault, A., Bertrand, G., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404318 · Cited by 54
Wu, G., Lin, L., Zhang, Q., & Wu, J. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.09.001 · Cited by 54
Sečník, J., Čermáková, P., Fereshtehnejad, S., Dannberg, P., Johnell, K., Fastbom, J., Winblad, B. G., Eriksdotter, M., & Religa, D. (2017) · Diabetes Care · doi:10.2337/dc16-2516 · Cited by 51
PINK1 deficiency in β-cells increases basal insulin secretion and improves glucose tolerance in mice
Deas, E., Piipari, K., Machhada, A., Li, A., del Arroyo, A. G., Withers, D. J., Wood, N. W., & Abramov, A. Y. (2014) · Open Biology · doi:10.1098/rsob.140051 · Cited by 48
Impact of Insulin Sensitizers on the Incidence of Dementia: A Meta-Analysis
Ye, F., Luo, Y.-J., Xiao, J. F., Yu, N., & Yi, G. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000445941 · Cited by 48
Insulin affects synaptosomal GABA and glutamate transport under oxidative stress conditions
Duarte, A. I., Santos, M. S., Seiça, R. M. F., & Oliveira, C. R. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02679-9 · Cited by 47
Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity
Bobela, W., Nazeeruddin, S., Knott, G. W., Aebischer, P., & Schneider, B. L. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0220-x · Cited by 46
Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
Ong, M., Foo, H., Chander, R. J., Wen, M., Au, W. L., Sitoh, Y. Y., Tan, L., & Kandiah, N. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.04.010 · Cited by 45
Yu, X., Jia, G.-R., Gao, G.-D., Wang, S., Han, Y., & Cao, W. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00152.x · Cited by 44
Parkinsonism-associated protein DJ-1 is a bona fide deglycase
Richarme, G., & Dairou, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.134 · Cited by 44
Innate Immune Function of Mitochondrial Metabolism
Sancho, D., Enamorado, M., & Garaude, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00527 · Cited by 43
Carlo, M. D., Picone, P., Carrotta, R., Giacomazza, D., & Biagio, P. L. S. (2010) · BioMed Research International · doi:10.1155/2010/147835 · Cited by 42
Gu, J., Ye, S., Wang, S., Sun, W., & Hu, Y. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132781 · Cited by 42
Cang, X., Wang, X., Liu, P., Wu, X., Jin, Y., Chen, J., Wu, G., Jin, Y., Xu, F., Su, J., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.004 · Cited by 41
Perfusion and metabolism imaging studies in Parkinson's disease.
Borghammer, P. (2012) · PubMed · Cited by 40
Kochkina, E. G., Plesneva, S. A., Vasilev, D. S., Zhuravin, I. A., Turner, A. J., & Nalivaeva, N. N. (2015) · Biogerontology · doi:10.1007/s10522-015-9569-9 · Cited by 40
Pre‐morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
Paganoni, S., Hyman, T. S., Shui, A. M., Allred, P., Harms, M. B., Liu, J., Maragakis, N. J., Schoenfeld, D., Yu, H., Atassi, N., et al. (2015) · Muscle & Nerve · doi:10.1002/mus.24688 · Cited by 37
Zuo, X., & Jia, J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.034 · Cited by 29
Li, N., Oquendo, E., Capaldi, R., Robinson, J. P., He, Y. D., Hamadeh, H. K., Afshari, C. A., Lightfoot-Dunn, R. M., & Narayanan, P. K. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu176 · Cited by 29
Porceddu, P. F., Ishola, I. O., Contu, L., & Morelli, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9633-5 · Cited by 28
Levine, T., Bowser, R. P., Hank, N. C., Gately, S. T., Stephan, D. A., Saperstein, D., & Keuren‐Jensen, K. R. V. (2012) · Neurology Research International · doi:10.1155/2012/582075 · Cited by 27
High Prevalence of Diabetes Mellitus in a Five-Generation Chinese Family with Huntington's Disease
Hu, Y., Liang, J., & Yu, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131847 · Cited by 25
Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels
Reitz, C., Cheng, R., Schupf, N., Lee, J. H., Mehta, P. D., Rogaeva, E. A., George‐Hyslop, P. S., & Mayeux, R. P. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.005 · Cited by 24
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients
Russo, C. V., Salvatore, E., Saccà, F., Tucci, T., Rinaldi, C., Sorrentino, P., Massarelli, M., Rossi, F., Savastano, S., Maio, L. D., et al. (2013) · Journal of Huntington s Disease · doi:10.3233/jhd-130078 · Cited by 23
Moosavi, M., Maghsoudi, N., Zahediasl, S., Naghdi, N., Yousefpour, M., & Trounce, I. A. (2008) · Neuroendocrinology · doi:10.1159/000150441 · Cited by 22
The Role of the Antioxidant Protein DJ-1 in Type 2 Diabetes Mellitus
Eberhard, D., & Lammert, E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6583-5_11 · Cited by 22
Identifying PD-causing genes and genetic susceptibility factors
Gasser, T. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)83001-8 · Cited by 21
Wang, S., Fei-yan, H., & Wang, Y. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988714554707 · Cited by 21
Yokoyama, H., Ogawa, M., Honjo, J., Okizaki, S.-I., Yamada, D., Shudo, R., Shimizu, H., Sone, H., & Haneda, M. (2014) · Diabetology International · doi:10.1007/s13340-014-0194-7 · Cited by 21
Danguir, J., Elghozi, J., & Laude, D. (1984) · Neurochemistry International · doi:10.1016/0197-0186(84)90028-7 · Cited by 21
Modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia
Lozovsky, D. B., Kopin, I. J., & Saller, C. F. (1985) · Brain Research · doi:10.1016/0006-8993(85)91178-3 · Cited by 20
Crane, P. K., Walker, R. L., Sonnen, J. A., Gibbons, L. E., Melrose, R. J., Hassenstab, J. J., Keene, C. D., Postupna, N. O., Montine, T. J., & Larson, E. B. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.021 · Cited by 18
No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
Gaare, J. J., Nido, G. S., Sztromwasser, P., Knappskog, P. M., Dahl, O., Lund‐Johansen, M., Alves, G. W., Tysnes, O., Johansson, S., Haugarvoll, K., et al. (2017) · Brain · doi:10.1093/brain/awx378 · Cited by 9
Turner, R. S., Craft, S., & Aisen, P. S. S. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.573 · Cited by 6
Reply: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
Fitzgerald, J. C., Zimprich, A. A., Bobbili, D. R., Sharma, M., May, P., & Krüger, R. (2018) · Brain · doi:10.1093/brain/awx380 · Cited by 2
Self-citation
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Masato, A., Plotegher, N., Boassa, D., & Bubacco, L. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0332-6 · Cited by 328
Metadata
- Authors
- Rotermund, C., Machetanz, G., & Fitzgerald, J. C.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-19
- Volume
- 9
- Pages
- 400-400
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W2884134082
- Cited by
- 304
- References
- 355
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.